Education
About Us
Working with TipRanks
Follow Us
Sotera Health (SHC)
NASDAQ:SHC
SHC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$9.53 - $17.08
Previous CloseN/A
Volume149.43K
Average Volume (3M)1.38M
Market Cap
$3.65B
Enterprise Value$5.35B
Total Cash (Recent Filing)$304.39M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)148.4
Beta0.89
Next Earnings
Aug 06, 2025EPS Estimate
0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.14
Shares Outstanding283,855,070
10 Day Avg. Volume1,259,279
30 Day Avg. Volume1,382,314
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.47
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda13.08
Forecast
1Y Price Target
$15.30Price Target Upside16.35% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
---
Bulls Say, Bears Say
Bulls Say
Business ModelSHC has a durable business model with exposure to commercial pharmaceutical and medical devices, which are less volatile in an economic downturn due to the necessary nature of the products.
Financial PerformanceSotera is able to deliver strong top line growth and EBITDA margins due to high barriers to entry, critical positioning within the manufacturing process of its customers, and strong customer retention rates.
Growth OpportunitiesSHC has a number of growth opportunities including driving synergies between Sterigenics and Nelson Labs, market consolidation following regulation changes, and capacity expansions.
Bears Say
Litigation RisksThere is caution regarding potential litigation risk within their EO sterilization facilities as they face a number of ongoing cases.
Revenue DeclineThe company faces a significant decline in RCA-related revenue in the first quarter, leading to a solidly negative volume and mix.
Supply Chain RisksEnd-market and supply chain risks are rising, reflecting broader challenges in the stock market.
---
Ownership Overview
Currently, No data available
---
SHC FAQ
What was Sotera Health’s price range in the past 12 months?
Sotera Health lowest stock price was $9.53 and its highest was $17.08 in the past 12 months.
What is Sotera Health’s market cap?
Sotera Health’s market cap is $3.65B.
When is Sotera Health’s upcoming earnings report date?
Sotera Health’s upcoming earnings report date is Aug 06, 2025 which is in 89 days.
How were Sotera Health’s earnings last quarter?
Sotera Health released its earnings results on May 01, 2025. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.122 by $0.018.
Is Sotera Health overvalued?
According to Wall Street analysts Sotera Health’s price is currently Undervalued.
Does Sotera Health pay dividends?
Sotera Health does not currently pay dividends.
What is Sotera Health’s EPS estimate?
Sotera Health’s EPS estimate is 0.17.
How many shares outstanding does Sotera Health have?
Sotera Health has 283,855,070 shares outstanding.
What happened to Sotera Health’s price movement after its last earnings report?
Sotera Health reported an EPS of $0.14 in its last earnings report, beating expectations of $0.122. Following the earnings report the stock price went up 5.217%.
Which hedge fund is a major shareholder of Sotera Health?
Currently, no hedge funds are holding shares in SHC
---
Sotera Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$15.30 (16.35% Upside)
$15.30 (16.35% Upside)
Blogger Sentiment
Bullish
SHC Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 3.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 9.4%
Last 30 Days ▼ 9.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
13.81%
12-Months-Change
Fundamentals
Return on Equity
5.88%
Trailing 12-Months
Asset Growth
1.24%
Trailing 12-Months
Company Description
Sotera Health
Sotera Health (SHC) is a leading global provider of mission-critical end-to-end sterilization solutions, lab testing, and advisory services for the healthcare industry. The company operates through three primary segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics offers comprehensive sterilization services using gamma, ethylene oxide, and electron beam technologies. Nordion supplies Cobalt-60, an essential isotope for gamma radiation sterilization and medical radiotherapy. Nelson Labs provides microbiological and analytical testing and consultancy services for the medical device, pharmaceutical, and tissue industries.
---
SHC Company Deck
---
SHC Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Sotera Health demonstrated robust growth in revenues and EBITDA, notably in Nelson Labs and Nordion, and maintained a positive outlook for 2025. However, challenges such as the Cobalt-60 shipment timing, a GAAP net loss due to legal settlements, and revenue decline in Nelson Labs advisory services were noted. Despite these lowlights, the positive developments and reaffirmed growth outlook suggest a resilient performance.Read More>---
SHC Stock 12 Month Forecast
Average Price Target
$15.30
▲(16.35% Upside)
Technical Analysis
Haemonetics
―
ICU Medical
―
Surgery Partners
―
Irhythm Technologies
―
Crispr Therapeutics AG
―
---